Cargando…
Excessive lysosomal ion-trapping of hydroxychloroquine and azithromycin
A recent report identified significant reductions or disappearance of viral load in COVID-19 patients given a combination of hydroxychloroquine and azithromycin. The present communication discusses some common pharmacokinetic properties of these two drugs that may be linked to a potential underlying...
Autor principal: | Derendorf, Hartmut |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier B.V. and International Society of Chemotherapy.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7204663/ https://www.ncbi.nlm.nih.gov/pubmed/32389720 http://dx.doi.org/10.1016/j.ijantimicag.2020.106007 |
Ejemplares similares
-
Hydroxychloroquine- and azithromycin-related heart disorders
Publicado: (2020) -
Hydroxychloroquine + azithromycin treatment in elderly patients
por: Gautret, Philippe, et al.
Publicado: (2021) -
Hydroxychloroquine or chloroquine +/- azithromycin: heart disorders
Publicado: (2022) -
Hydroxychloroquine-azithromycin for COVID-19 – Warranted or dangerous?
por: Popescu, Corneliu P., et al.
Publicado: (2020) -
QT interval prolongation with hydroxychloroquine plus azithromycin
Publicado: (2020)